Cargando…
The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review
INTRODUCTION: There has been increasing interest in pragmatic trials methodology. As a result, tools such as the Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) are being used prospectively to help researchers design randomised controlled trials (RCTs) within the pragmatic-explanatory...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588964/ https://www.ncbi.nlm.nih.gov/pubmed/28871028 http://dx.doi.org/10.1136/bmjopen-2017-017887 |
_version_ | 1783262255355265024 |
---|---|
author | Aves, Theresa Allan, Katherine S Lawson, Daeria Nieuwlaat, Robby Beyene, Joseph Mbuagbaw, Lawrence |
author_facet | Aves, Theresa Allan, Katherine S Lawson, Daeria Nieuwlaat, Robby Beyene, Joseph Mbuagbaw, Lawrence |
author_sort | Aves, Theresa |
collection | PubMed |
description | INTRODUCTION: There has been increasing interest in pragmatic trials methodology. As a result, tools such as the Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) are being used prospectively to help researchers design randomised controlled trials (RCTs) within the pragmatic-explanatory continuum. There may be value in applying the PRECIS-2 tool retrospectively in a systematic review setting as it could provide important information about how to pool data based on the degree of pragmatism. OBJECTIVES: To investigate the role of pragmatism as a source of heterogeneity in systematic reviews by (1) identifying systematic reviews with meta-analyses of RCTs that have moderate to high heterogeneity, (2) applying PRECIS-2 to RCTs of systematic reviews, (3) evaluating the inter-rater reliability of PRECIS-2, (4) determining how much of this heterogeneity may be explained by pragmatism. METHODS: A cross-sectional methodological review will be conducted on systematic reviews of RCTs published in the Cochrane Library from 1 January 2014 to 1 January 2017. Included systematic reviews will have a minimum of 10 RCTs in the meta-analysis of the primary outcome and moderate to substantial heterogeneity (I(2)≥50%). Of the eligible systematic reviews, a random selection of 10 will be included for quantitative evaluation. In each systematic review, RCTs will be scored using the PRECIS-2 tool, in duplicate. Agreement between raters will be measured using the intraclass correlation coefficient. Subgroup analyses and meta-regression will be used to evaluate how much variability in the primary outcome may be due to pragmatism. DISSEMINATION: This review will be among the first to evaluate the PRECIS-2 tool in a systematic review setting. Results from this research will provide inter-rater reliability information about PRECIS-2 and may be used to provide methodological guidance when dealing with pragmatism in systematic reviews and subgroup considerations. On completion, this review will be submitted to a peer-reviewed journal for publication. |
format | Online Article Text |
id | pubmed-5588964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-55889642017-09-14 The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review Aves, Theresa Allan, Katherine S Lawson, Daeria Nieuwlaat, Robby Beyene, Joseph Mbuagbaw, Lawrence BMJ Open Research Methods INTRODUCTION: There has been increasing interest in pragmatic trials methodology. As a result, tools such as the Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) are being used prospectively to help researchers design randomised controlled trials (RCTs) within the pragmatic-explanatory continuum. There may be value in applying the PRECIS-2 tool retrospectively in a systematic review setting as it could provide important information about how to pool data based on the degree of pragmatism. OBJECTIVES: To investigate the role of pragmatism as a source of heterogeneity in systematic reviews by (1) identifying systematic reviews with meta-analyses of RCTs that have moderate to high heterogeneity, (2) applying PRECIS-2 to RCTs of systematic reviews, (3) evaluating the inter-rater reliability of PRECIS-2, (4) determining how much of this heterogeneity may be explained by pragmatism. METHODS: A cross-sectional methodological review will be conducted on systematic reviews of RCTs published in the Cochrane Library from 1 January 2014 to 1 January 2017. Included systematic reviews will have a minimum of 10 RCTs in the meta-analysis of the primary outcome and moderate to substantial heterogeneity (I(2)≥50%). Of the eligible systematic reviews, a random selection of 10 will be included for quantitative evaluation. In each systematic review, RCTs will be scored using the PRECIS-2 tool, in duplicate. Agreement between raters will be measured using the intraclass correlation coefficient. Subgroup analyses and meta-regression will be used to evaluate how much variability in the primary outcome may be due to pragmatism. DISSEMINATION: This review will be among the first to evaluate the PRECIS-2 tool in a systematic review setting. Results from this research will provide inter-rater reliability information about PRECIS-2 and may be used to provide methodological guidance when dealing with pragmatism in systematic reviews and subgroup considerations. On completion, this review will be submitted to a peer-reviewed journal for publication. BMJ Publishing Group 2017-09-03 /pmc/articles/PMC5588964/ /pubmed/28871028 http://dx.doi.org/10.1136/bmjopen-2017-017887 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Research Methods Aves, Theresa Allan, Katherine S Lawson, Daeria Nieuwlaat, Robby Beyene, Joseph Mbuagbaw, Lawrence The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title | The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title_full | The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title_fullStr | The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title_full_unstemmed | The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title_short | The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
title_sort | role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review |
topic | Research Methods |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588964/ https://www.ncbi.nlm.nih.gov/pubmed/28871028 http://dx.doi.org/10.1136/bmjopen-2017-017887 |
work_keys_str_mv | AT avestheresa theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT allankatherines theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT lawsondaeria theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT nieuwlaatrobby theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT beyenejoseph theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT mbuagbawlawrence theroleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT avestheresa roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT allankatherines roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT lawsondaeria roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT nieuwlaatrobby roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT beyenejoseph roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview AT mbuagbawlawrence roleofpragmatisminexplainingheterogeneityinmetaanalysesofrandomisedtrialsaprotocolforacrosssectionalmethodologicalreview |